PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Seeking Alpha
Company Participants Ellen Cavaleri Matthew Klein - CEO & Director Eric Pauwels - Chief Business Officer Pierre Gravier - Chief Financial Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald & Co., Research Division Tazeen Ahmad - BofA Securities, Research Division Eliana Merle - Barclays Bank PLC, Research Division Lut Ming Cheng - JPMorgan Chase & Co, Research Division Judah Frommer - Morgan Stanley, Research Division Benjamin Burnett - Wells Fargo Securities, LLC, Research Division Joseph Thome - TD Cowen, Research Division Samantha Corwin - William Blair & Company L.L.C., Research Division Jarwei Fang Luke Herrmann - Robert W. Baird & Co. Incorporated, Research Division Kyuwon Choi - Goldman Sachs Group, Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] Today's conferen
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- PTC Therapeutics (PTCT) was upgraded by Raymond James Financial, Inc. to "moderate buy".MarketBeat
- PTC Therapeutics (PTCT) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $108.00 price target on the stock.MarketBeat
- How The PTC Therapeutics (PTCT) Story Is Shifting With Sephience And DMD Uncertainty [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics (PTCT) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $76.00 price target on the stock, down from $91.00.MarketBeat
- PTC Therapeutics (PTCT) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
PTCT
Earnings
- 2/19/26 - Miss
PTCT
Sec Filings
- 4/8/26 - Form 4
- 4/6/26 - Form 4
- 4/6/26 - Form 144
- PTCT's page on the SEC website